TRAWS PHARMA, INC. (TRAW)
Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections
Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections
Plus Therapeutics Announces Oral Presentation Highlighting REYOBIQ™ Clinical and Translational Data Demonstrating Favorable Safety, Survival, and Emerging Immunomodulation in Leptomeningeal Metastases
Soligenix Announces Recent Updates and First Quarter 2026 Financial Results
Vistagen Announces Completion of Last Patient Visit in PALISADE-4 Phase 3 Public Speaking Challenge Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
On World Ovarian Cancer Day, LGSOC Resource Guide Launches to Support People Living with Low-Grade Serous Ovarian Cancer
PPL Corporation delivers solid first-quarter 2026 earnings; reaffirms full‑year guidance and long‑term growth targets
Alpha Releases First Quarter 2026 Financial Results
Madison Square Garden Sports Corp. Reports Fiscal 2026 Third Quarter Results
FIS Reports First Quarter 2026 Results and Reiterates Full-Year Outlook
FH Capital to Acquire 75.1% Majority Stake in JinkoSolar’s U.S. Manufacturing Operations, Establishing a Premier Domestic Solar and BESS Platform